Hansoh Pharmaceutical Group Co., Ltd. (3KY)
FSX
3.70
+0.02 (+0.49%)
Real-time Data
06:00 AM
Day's Range
3.683.70
52 wk Range
3.094.80
Financial Statements - 3KY - Hansoh Pharmaceutical Group Co., Ltd.
Revenue
15.02B▲ 22.6%
Net Income
5.55B▲ 27.1%Net Margin 37.0%
EBITDA
6.97B▲ 28.0%
Free Cash Flow
6.24B▲ 87.2%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 15.02B | 12.26B | 10.10B | 9.38B | 9.93B | 1.14B |
| Cost of Goods | 1.49B | 1.10B | 1.03B | 867.01M | 870.04M | 105.96M |
| Gross Profit | 13.53B | 11.15B | 9.07B | 8.51B | 9.06B | 1.04B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 5.54B | 4.03B | 2.83B | 2.79B | 3.03B | 374.11M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 6.55B | 5.08B | 3.76B | 2.94B | 3.30B | 409.57M |
| Income Tax | 995.12M | 713.35M | 488.65M | 364.68M | 587.18M | 69.98M |
| Net Income | 5.55B | 4.37B | 3.27B | 2.58B | 2.71B | 339.59M |
| EPS Basic | 0.93 | 0.74 | 0.55 | 0.44 | 0.46 | 0.44 |
| EPS Diluted | 0.93 | 0.73 | 0.52 | 0.44 | 0.44 | 0.44 |
| Basic Shares Outstanding | 5.96B | 5.93B | 5.92B | 5.91B | 49B | 5.87B |
| Diluted Shares Outstanding | 5.96B | 5.93B | 5.92B | 5.91B | 49B | 5.87B |
| Ebit | 6.55B | 5.09B | 3.83B | 3B | 3.35B | 409.79M |
| Ebitda | 6.97B | 5.45B | 4.06B | 3.28B | 3.65B | 435.53M |
| Net Income Continuous Operations | 6.55B | 5.08B | 3.76B | 2.94B | 3.30B | 409.57M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
